Aimmune Therapeutics, Inc. (AIMT) related to its sale to Sociétés des Produits Nestlé, S.A. Under the terms of the agreement, Aimmune shareholders will receive $34.50 per share for each share of Aimmune stock owned.
Aimmune Therapeutics, Inc. (AIMT) related to its sale to Sociétés des Produits Nestlé, S.A. Under the terms of the agreement, Aimmune shareholders will receive $34.50 per share for each share of Aimmune stock owned.